GlassScriptPhysician profile
Amaiak Chilingaryan
NPI 1134433568
$31,988.12
in general payments reported to CMS, 2019-2025
76 companies · $6,077 in 2025
The $6,077 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,510 · 2020: $2,835 · 2021: $3,785 · 2022: $5,160 · 2023: $5,538 · 2024: $6,084 · 2025: $6,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,447.62 |
| Education | $251.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $2,963.92 | 2019-2025 | Rystiggo, Fintepla, Zilbrysq |
| Teva Pharmaceuticals USA, INC. | $1,901.53 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Sk Life Science, INC. | $1,847.30 | 2020-2025 | Xcopri |
| Abbvie INC. | $1,481.12 | 2020-2025 | Ubrelvy, Qulipta |
| Acadia Pharmaceuticals INC | $1,364.19 | 2019-2025 | Nuplazid |
| Emd Serono, INC. | $1,329.66 | 2019-2025 | Mavenclad, Mavenclad |
| Lundbeck LLC | $1,142.92 | 2021-2025 | Rexulti, Vyepti |
| Amneal Pharmaceuticals LLC | $1,077.44 | 2019-2025 | Rytary, Crexont |
| Biogen, INC. | $975.19 | 2019-2025 | Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $912.05 | 2019-2025 | |
| Argenx US, INC. | $886.28 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Alexion Pharmaceuticals, INC. | $837.69 | 2022-2025 | Ultomiris, Soliris |
| Avanir Pharmaceuticals, INC. | $756.24 | 2019-2022 | |
| Mdd US Operations, LLC | $726.71 | 2019-2025 | Gocovri, Apokyn, Apokyn |
| Neurelis, INC. | $716.68 | 2023-2025 | Valtoco |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $695.39 | 2019-2024 | Amvuttra |
| Sunovion Pharmaceuticals INC. | $690.58 | 2019-2022 | |
| Genzyme Corporation | $687.60 | 2019-2025 | |
| Amgen INC. | $680.18 | 2019-2025 | Uplizna, Aimovig |
| Lilly USA, LLC | $625.26 | 2019-2025 | Kisunla, Emgality, Amyvid |
| Celgene Corporation | $601.53 | 2022-2025 | Zeposia |
| Neurocrine Biosciences, INC. | $601.48 | 2019-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $578.58 | 2023-2025 | Nuedexta, Rexulti |
| Acorda Therapeutics, INC | $572.27 | 2019-2023 | Inbrija, Ampyra |
| Kyowa Kirin, INC. | $446.24 | 2019-2024 | Nourianz |
| Csl Behring | $422.74 | 2019-2025 | Hizentra |
| Abbott Laboratories | $381.79 | 2019-2025 | Amplatzer, Infinity |
| Glaxosmithkline, LLC. | $347.49 | 2019-2024 | Trelegy Ellipta |
| Supernus Pharmaceuticals, INC. | $343.16 | 2019-2025 | Qelbree, Trokendi Xr, Oxtellar Xr |
| Eisai INC. | $312.59 | 2020-2024 | |
| Pfizer INC. | $292.95 | 2023-2025 | |
| Livanova USA, INC. | $289.44 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Ani Pharmaceuticals, INC. | $237.64 | 2024-2025 | Purified Cortrophin Gel |
| Catalyst Pharmaceuticals, INC. | $231.85 | 2020-2025 | Fycompa, Firdapse |
| Merck Sharp & Dohme LLC | $219.28 | 2020-2023 | Belsomra |
| Grifols USA, LLC | $205.68 | 2022-2025 | Gamunex-C |
| Adamas Pharmaceuticals, INC. | $195.19 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $186.24 | 2019-2025 | Ztlido |
| Corium, LLC | $183.24 | 2023 | Adlarity |
| Banner Life Sciences, LLC | $183.01 | 2022-2023 | |
| Greenwich Biosciences, INC. | $173.90 | 2019-2021 | |
| Boston Scientific Corporation | $172.76 | 2023 | Watchman |
| Allergan, INC. | $163.76 | 2020 | |
| Janssen Biotech, INC. | $154.13 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $147.84 | 2021 | |
| Sumitomo Pharma America, INC. | $141.67 | 2023-2024 | Aptiom |
| Bausch Health US, LLC | $138.09 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $137.69 | 2022 | |
| Janssen Pharmaceuticals, INC | $127.76 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $126.90 | 2022-2023 | Gammagard |
| Idorsia Pharmaceuticals US INC | $103.69 | 2023-2024 | Quviviq |
| Vanda Pharmaceuticals INC. | $95.56 | 2024-2025 | Ponvory |
| Merz Pharmaceuticals, LLC | $88.43 | 2025 | Xeomin, Ampyra, Inbrija |
| Collegium Pharmaceutical, INC. | $85.98 | 2022 | |
| Jazz Pharmaceuticals INC. | $85.54 | 2022-2025 | |
| Currax Pharmaceuticals LLC | $84.81 | 2022-2024 | Onzetra Xsail |
| Astrazeneca Pharmaceuticals LP | $84.11 | 2021 | |
| Almatica Pharma LLC | $78.37 | 2021-2023 | Gralise, Loreev Xr |
| Tanabe Pharma America, INC. | $77.04 | 2022-2024 | |
| Medtronic, INC. | $72.43 | 2022 | |
| Cycle Pharmaceuticals INC | $59.85 | 2025 | Tascenso Odt, Bafiertam |
| Impel Pharmaceuticals INC. | $54.46 | 2022-2023 | Trudhesa |
| Forte Bio-Pharma LLC | $50.38 | 2025 | Tanlor |
| Strongbridge US INC. | $43.28 | 2020 | |
| Horizon Therapeutics Plc | $39.74 | 2022-2023 | Uplizna |
| Azurity Pharmaceuticals, INC. | $38.00 | 2025 | |
| Xeris Pharmaceuticals, INC. | $33.47 | 2021-2023 | Keveyis |
| Redhill Biopharma INC. | $31.90 | 2020 | |
| Ge Healthcare | $29.97 | 2024 | |
| Promius Pharma LLC | $25.08 | 2019 | |
| Cala Health, INC. | $24.41 | 2022 | |
| Aucta Pharmaceuticals, INC. | $22.13 | 2025 | Motpoly Xr |
| Mallinckrodt Hospital Products INC. | $19.15 | 2024 | Acthar |
| Arbor Pharmaceuticals, INC. | $18.58 | 2021 | |
| Axsome Therapeutics, INC. | $15.01 | 2025 | Sunosi |
| Vertical Pharmaceuticals, LLC | $11.93 | 2019 |
Drugs and devices associated with these payments
Nuplazid $778Rexulti $759Valtoco $717Ubrelvy $693Ultomiris $632Rystiggo $567Fintepla $546Austedo Xr $520Qulipta $508Zilbrysq $503Vyvgart $469Vyepti $402Zeposia $391Rytary $347Crexont $341Kesimpta $328Nuedexta $314Gocovri $312Vumerity $305Mavenclad $305Vyvgart Hytrulo $295Nurtec Odt $293Purified Cortrophin Gel $238Apokyn $220Hizentra $219Amplatzer $199Briviact $194Kisunla $186Amvuttra $184Adlarity $183Ingrezza $173Watchman $173Nayzilam $169Qelbree $166Emgality $160Zavzpret $158Inbrija $154Ampyra $154Trelegy Ellipta $143Aptiom $142Ztlido $140Fycompa $139Austedo $128Nourianz $124Uplizna $105Quviviq $104Xcopri $99.75Ponvory $95.56Belsomra $82.11Amyvid $80.53Gamunex-C $79.14Bafiertam $75.62Reyvow $75.37Vraylar $68.89Ajovy $63.40Xeomin $62.81Epidiolex $60.35Tascenso Odt $59.85Gammagard $59.74Botox $57.58Radicava Ors $56.61Radicava $56.61Leqembi $56.01Onzetra Xsail $50.42Tanlor $50.38Tysabri $43.87Trudhesa $42.30Infinity $40.87Mayzent $37.45Duopa $35.96Elyxyb - Celecoxib $34.07Gralise $27.95Loreev Xr $27.95Vns Therapy Sentiva Model 1000 Generator $27.00Firdapse $26.18Exservan $25.91Vyalev $24.16Zepbound $24.10Aubagio $23.74Motpoly Xr $22.13Soliris $19.66Acthar $19.15Aimovig $18.65Keveyis $17.76Oxtellar Xr $16.08Trokendi Xr $16.08Sunosi $15.01
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amaiak Chilingaryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.